Free News Archives
Latest Issue of OR Manager
February 2025

California pharmacists to begin testing patients for COVID-19

Editor's Note On May 12, California's Governor Gavin Newsom announced that California pharmacists will be allowed to collect specimens and order COVID-19 tests. Specimens will be are processed at public health, university, or commercial labs. The move is an effort to increase the state’s testing capacity as it modifies its…

Read More

By: Judy Mathias
May 14, 2020
Share

Provider burnout, fatigue during COVID-19 pandemic

Editor's Note This article from Houston Methodist Hospital and Texas A&M University researchers shares the lessons learned by an interdisciplinary team of ICU healthcare providers and their experiences of occupational fatigue and burnout as a result of the COVID-19 pandemic. The researchers documented four major areas of stress with the…

Read More

By: Judy Mathias
May 14, 2020
Share

FDA accelerates development of COVID-19 prevention, treatment options

Editor's Note The Food & Drug Administration on May 11 took new actions to accelerate the development of novel prevention and treatment options for COVID-19. The agency is providing guidance documents to make the process for submitting applications to initiate studies for new drugs and biological products more efficient. The…

Read More

By: Judy Mathias
May 14, 2020
Share

University of Kentucky researchers studying COVID-19 immunity

Editor's Note The University of Kentucky (UK) announced May 11 that researchers have begun antibody testing that will help to understand what immunity to COVID-19 really means. Several research labs within the UK College of Medicine and Pharmacy will be testing antibodies of recovered COVID-19 patients to see how long…

Read More

By: Judy Mathias
May 13, 2020
Share

CMS releases proposed inpatient payment rule for FY 2021

Editor's Note The Centers for Medicare & Medicaid Services (CMS) on May 11 released a proposed rule that increases Medicare inpatient prospective payment system (IPPS) rates by a net of 3.1% in FY 2021, compared to 2020, for acute care hospitals participating in the Hospital Inpatient Quality Reporting Program that…

Read More

By: Judy Mathias
May 13, 2020
Share

AI diagnostic predicts COVID-19 without testing

Editor's Note In this study, researchers at the Massachusetts General Hospital, Boston; King’s College, London; and health science company Zoe Global, Accra, Ghana; developed an artificial intelligence (AI) diagnostic that can predict whether someone is likely to have COVID-19 based on their symptoms. The researchers analyzed data from 2,618,862 people…

Read More

By: Judy Mathias
May 12, 2020
Share

Dr Gawande stepping down as Haven CEO

Editor's Note The May 8 Wall Street Journal reports that Atul Gawande, MD, is stepping away from the day-to-day operations of  Haven—the Amazon, JPMorgan, Berkshire Hathaway healthcare venture. Instead Dr Gawande will be chairman of the joint venture so he can focus more on policy and advocacy work, particularly related…

Read More

By: Judy Mathias
May 12, 2020
Share

Anticoagulants may improve survival in hospitalized COVID-19 patients

Editor's Note Treating hospitalized COVID-19 patients with anticoagulants may improve their chances of survival, this study from Mount Sinai finds. Of 2,773 COVID-19 patients analyzed, 786 received a full-treatment dose of anticoagulants, which was a higher dose than that typically given for clot prevention; it is one usually given to…

Read More

By: Judy Mathias
May 11, 2020
Share

CDC updates weekly COVID-19 stats

Editor's Note: The Centers for Disease Control and Prevention on May 8 updated it weekly surveillance summary of COVID-19 activity in the US for week 18. Among the updates: The percentage of specimens testing positive for SARS-CoV-2 decreased at public health, commercial, and clinical laboratories. Labs have confirmed 832,238 positive…

Read More

By: Judy Mathias
May 11, 2020
Share

Massachusetts researchers advance a novel gene-based COVID-19 vaccine

Editor's Note Researchers at the Massachusetts Eye and Ear, Massachusetts General Hospital, and Mass General Brigham, announced May 5 their progress towards the testing and development of an experimental vaccine against SARS-CoV-2 called AAVCOVID. The vaccine is currently in preclinical development with a plan to begin clinical testing in humans…

Read More

By: Judy Mathias
May 7, 2020
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat